Back

Polygenic risk score is associated with high-risk plaque and coronary plaque burden in patients with non-obstructive coronary artery disease

28 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Biological determinants of atherosclerosis Imaging ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Emilie Louise Gaillard

Amsterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Glucose-to-potassium ratio independently predicts long-term adverse outcomes in patients with coronary artery disease after PCI
Miss K. Zhang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Olink proteomic inflammatory biomarkers enhance precision risk prediction for long-term outcomes in coronary artery disease
Miss K. Zhang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Genetic determinants of coronary resilience: why do some high-risk individuals escape coronary artery disease?
Doctor F. Sousa (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Coronary artery calcium predicts 5-year all-cause-, non-cardiovascular-, and cancer mortality
Professor J. Anderson (Murray, US)
Abstract Slides Video

Access the full session

Session thumbnail
Biological determinants of atherosclerosis

The Event

Event poster

ESC Congress 2026

28 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Integrated clinical and polygenic coronary artery disease risk score predicts 10-year progression of coronary artery plaque
31 August 2026
thumbnail
Congress Presentation
Artificial intelligence-based automated plaque quantification from CCTA to predict acute coronary syndrome on top of obstructive or ischemic coronary artery disease
30 August 2024
thumbnail
Congress Presentation
PRS in coronary artery disease.
27 August 2022
thumbnail
Congress Presentation
Enhancing cardiovascular risk assessment: the opportunity of polygenic risk scoring as an earlier CT triage tool in primary prevention (the BioHEART-CT study)
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources